NeuroOne Medical Technologies Corporation - Common Stock (NMTC)

NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit Virtual Conference presentations are now available for on-demand viewing.

EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

NeuroOne Medical Technologies (NASDAQNMTC) is committed to improving surgical care options and outcomes for patients suffering from neurological disorders including epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries. The company’s minimally invasive and high-definition/high-precision solutions offer combination diagnostic and therapeutic functions for EEG recording, tissue ablation, as well as potentially for deep brain stimulation. Along with three FDA-cleared product families, Evo(R) Cortical Electrodes, Evo(R) sEEG Electrodes, and the OneRF(R) Ablation System, the company is engaged in R&D for drug delivery and spinal cord stimulation programs and is exploring potential applications of its medical technology using artificial intelligence. For more information, visit the company’s website at www.nmtc1.com .

EDEN PRAIRIE, MN / ACCESSWIRE / April 6, 2023 / As medical technology progresses, the world's approach to surgical operations is also advancing and changing significantly. As part of this, minimally invasive surgery (MIS), in recent years, has taken the forefront of the surgical industry, and there are no surprises why.

Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart. The improper signaling pathway causes the heart to beat too rapidly, which is tachycardia, or too gradually, which is bradycardia, or inconsistently. To avoid […]

NeuroOne Medical Technologies (NASDAQNMTC) is shaking off the effects of a weak broader market. In fact, since the start of February, NMTC shares are trading higher by more than 21% to $2.10* intraday on Friday. And while its down from its more impressive leap to $2.96 earlier in the month, holding its double digit gains shows that NMTC can decouple from general market weakness. Not only that, recent movement suggests that bullish momentum is on its side. Why? All indicators point toward investors embracing NeuroOne's innovative electrode technology, which revolutionizes the industry and could capture a significant share of the multi-billion-dollar electrode market. Better yet, NMTC could be capitalizing on market opportunities with little to no competition. (* share price noted reflects price on 2/25/22, 1:53pm est, Yahoo! Finance )

NeuroOne Medical Technologies (NASDAQNMTC) is bucking the trend of market weakness. In fact, since the start of February, NMTC shares are trading higher by more than 52% to $2.59 intraday on Friday. And that's down from a more impressive leap to $2. 79 earlier in the day on a NASDAQ market lower by triple digits. Why is NMTC decoupling from broader market weakness? Likely because NeuroOne has developed and marketed groundbreaking electrode technologies that can capture multi-billion-dollar niche markets with little to no competition.

There's a reason why NeuroOne Medical Technologies (NASDAQNMTC ) stock has been higher by more than 39% since the start of February- they have best-in-class products serving multiple billion-dollar market opportunities. Not only that, NMTC products are so specialized that their competitive landscape may stay more than thin; it can be non-existent. Hence, despite its massive month-to-date surge, NMTC stock is simply too good to ignore at current levels.

Today there is a massive $13.6 billion neurostimulation devices market developing for the ongoing study of the vast arrays of the brain’s neural connections. (1) The diagnostic electrode technology currently used to detect neurological disorders is the same that was developed way back in the 1960s. (2) This is where NeuroOne Medical Technologies (NASDAQNMTC) comes into play.

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The virtual conference begins on Tuesday, February 8th, 2022, with company presentations beginning at 8:30 am Eastern Time. Presentations will be webcast on Tuesday and

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors throughout the event. John Hope Bryant, guest host on CNBC and CEO of Operation HOPE will deliver the keynote to kick off the

RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified investors throughout the three-day event. Company Presentations will begin July 13 at 10 am eastern time and go through July 15th. The event will also include a keynote speaker (to be